Streetbeat News

Stock Prices

BLTE

Analysts have provided bullish ratings for Belite Bio (NASDAQ:BLTE) in the last quarter, with 5 bullish, 2 somewhat bullish, and no bearish or indifferent ratings. The average 12-month price target for Belite Bio is $49.57, a decrease of 14.53% from the previous average price target of $58.00.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 7:00 pm

SMCI

Super Micro Computer's shares are trading higher, rebounding after a recent fall due to Q4 earnings.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 7:00 pm

ARRY

Over the past 3 months, 7 analysts have published their opinion on Array Technologies (NASDAQ:ARRY) stock. The average price target for the stock is $29.71, with a high of $37.00 and a low of $16.00. The average price target has increased by 13.4% over the past month.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 7:00 pm

OLMA

Analysts have provided bullish and somewhat bullish ratings for Olema Pharmaceuticals (NASDAQ:OLMA) in the last quarter. According to 4 analysts offering 12-month price targets in the last 3 months, Olema Pharmaceuticals has an average price target of $19.25, which has increased by 22.85% over the past month.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 7:00 pm

INFA

In the last quarter, Informatica (NYSE:INFA) received one somewhat bullish rating and four indifferent ratings from analysts. The company's average 12-month price target is $22.2, up 13.85% from the previous average of $19.50.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 7:00 pm

ANSS

Ansys (NASDAQ:ANSS) has outperformed the market over the past 20 years by 11.43% on an annualized basis, producing an average annual return of 19.15%. If an investor had bought $1000 of ANSS stock 20 years ago, it would be worth $34,368.00 today.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 7:00 pm

ETNB

89bio (NASDAQ:ETNB) has received 5 bullish analyst ratings in the last quarter, with an average price target of $38.8, implying significant upside from the current price of $16.22. The average price target has increased by 11.91% over the past month.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 7:00 pm

FNF

Analysts have provided mostly bullish ratings for Fidelity National Finl (FNF) in the last quarter, with an average price target of $47.75. This target has increased by 0.53% over the past month.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 7:00 pm

MDB

MongoDB (NASDAQ:MDB) has outperformed the market over the past 5 years by 31.51% on an annualized basis, producing an average annual return of 40.99%. If an investor had bought $1000 of MDB stock 5 years ago, it would be worth $5,680.74 today.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 7:00 pm

EBIX

Ebix shares continue to trade lower following the company's worse-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 6:58 pm